Hamilton Glaucoma Center, Shiley Eye Institute, and the Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, CA
N.W.E.-N. and E.M. contributed equally and should be considered first co-authors.
National Institutes of Health/National Eye Institute Grants EY11008, EY19869, EY14267, EY027510, EY026574, EY027945, EY029058, P30EY022589, Unrestricted grant from Research to Prevent Blindness, New York, New York.
Disclosure: N.W.E.-N.: current employment at Topcon Healthcare, but all work related to the current manuscript was done before employment. L.M.Z.: F: National Eye Institute, Carl Zeiss Meditec Inc., Heidelberg Engineering GmbH, Optovue Inc., Topcon Medical Systems Inc. R.N.W.: F: National Eye Institute, Heidelberg Engineering, Carl Zeiss Meditec, Konan, Optovue, Topcon, Centervue. C: Aerie Pharmaceuticals, Alcon, Allergan, Bausch & Lomb, Equinox, Eyenovia. The remaining authors declare no conflict of interest.
Reprints: Robert N. Weinreb, MD, Hamilton Glaucoma Center and the Shiley Eye Institute, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0946 (e-mail: [email protected]).
